Zusammenfassung der Ressource
Treaments
- Antipsychotic Drugs and Dopamine
- Chlorpromazine relieves positive
symptoms of schizo for most patients
- antipsychotic/neuroleptic
drugs in 2 chemical families
- phenothiazines including
chlorpromazine
- butyrophenones
include haloperiodol
- behavioural benefits of these drugs
develop gradually over month+
- symptoms generally return
after cessation of treatment
- block dopamine synapses
- inspired dopamine hypothesis of
schizophrenia
- holds schizo results from excess
activity at dopamine synapses in
certain brain areas
- concentration of dopamine in brain no higher
than normal, turnover is elevated especially in
basal ganglia
- KUMAKURA ET AL 2007
- neurons release dopamine at faster than average rate
and synthesise more to replace molecules that they do
not reabsorb
- elevated dopamine release also occurs in people showing
first symptoms of schizo
- HOWS ET AL 2009
- support for dopamine hypothesis
comes from fact late, repeated use of
amphetamine, methamphetamine
- or cocaine induces
substance induced
psychotic disorder
- characterised by hallucinations and delusions (positive
symptoms)
- each drug increases prolongs
activity at dopamine synapses
- LSD produced psychotic symptoms best
known for effects on serotonin synapses
but also stimulates dopamine synapses
- researchers set out to measure number of
dopamine receptors occupies given moment
- used radioactively labeled drug, IBZM that
binds to dopamine type D2 receptors
- because IBZM binds only to receptors that dopamine
didn't already bind, measuring radioactivity counts
number of vacant dop receptors
- used second drug AMPT to block all synthesis of dopamine and again
used IBZM to count number of vacant D2 receptors
- because AMPT had revenged production of dopamine,
all D2 receptors should be vacant so researchers got a
count of the total
- they subtracted first count of second count,
yielding number of D2 receptors occupied by
dopamine at first count
- first: IBZM binds to D3
receptors not already
attached to dopamine
- second: IBZM binds to all
D2 receptors because
AMPT eliminated
production of dopamine
- second count minus first equals
number of D2 receptors bound
to dopamine at first count
- researchers found people with
schizo had twice as many D2
receptors occupied as normal
- Role of Glutamate
- glutamate hypothesis of schizo
- problem relates in part to deficient activity at
glutamate synapses, especially in prefrontal cortex
- many brain areas dopamine inhibits glutamate
release or glutamate stimulates neurons that inhibit
dopamine release
- increased dopamine would produce same
effects as decreased glutamate
- antipsychotic effects of drugs block dopamine compatible
with either excess dopamine hypothesis or deficient
glutamate hypothesis
- schizo assoc with lower than normal release of glutamate and
fewer than normal receptors in prefrontal cortex and hippo
- similar in those high at risk for developing
schizo due to family background
- support for glutamate hyp of schizoi
from effects of phencyclidine (PCP)
- inhibits NMDA glutamate receptors
- low doses produces
intoxication and slurred
speech
- high doses produces both negative and positive symptoms of
schizo including hallucination though disorder, loss of emotions
and memory loss
- PCP and ketamine produce little if any
psychotic response in preadolescents
- just as symptoms of schizo usually begin emerge
well after puberty, so do psychotic effects of PCP
and ket
- LSD, coke and amphetamine produce temp schizo symptoms in
anyone and effects aren't much worse with this with history of
schizo
- PCP produces severe effects for
someone recoveringg form schizo
- administer glutamate itself?
- strokes kill neurones by
overstimulating glutamate synapses
- too risky
- drugs stimulating particular kinds of
metabotropic glutamate receptors have
shown promise in treating schizo
- PATIL ET AL 2007
- New Drugs
- brian had several dopamine
pathways with diff functions
- drugs that block dopamine synapses
produce benefits by acting on neurones in
mesolimbocortical system
- set of neurons that project from
midbrain tegmentum to the limbic system
- drug also blocks dopamine neurons
in mesostriatal system projects to
basal ganglia
- effect on basal ganglia produces tardive dyskinesia
- characterised by tremors and involuntary movement that develop
gradually to varying degrees among different patients
- once tardive dyskinesia emerges, can last
long after someone quits the drug
- KIRIAKAKIS ET AL 1998
- second-generation antipsychotics alleviate schizo
without producing movement problems
- most common is clozapine, risperidone, apripipazole
- more effective than older drugs at treating
negative symptoms of schizo and now used
more widely
- other side effects like weight
game and impairment of immune
system
- don't improve quality of life
much more than older drugs